SCHEMBL7731723

SCHEMBL7731723

CC(C)(C)OC(=O)NCC(=O)NC1C[C@@H](C(=O)Nc2ccc(Nc3ccccc3)cc2)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 6/20 0.44
POLB P06746 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPC1 O15118 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
GFER P55789 1/20 0.41
NPFFR1 Q9GZQ6 1/20 0.40
NPFFR2 Q9Y5X5 1/20 0.40
TLR2 O60603 1/20 0.39
TLR1 Q15399 1/20 0.39
PABPC1 P11940 1/20 0.39
HTRA1 Q92743 1/20 0.39
NAMPT P43490 2/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7726519 0.91 POLB (0.42) HDAC8POLBCYP1A2CYP3A4CYP2C19
SCHEMBL7731475 0.91 HDAC8 (0.44) HDAC8POLBCYP1A2CYP3A4CYP2C19
SCHEMBL7725703 0.89 POLB (0.43) HDAC8POLBCYP1A2CYP3A4CYP2C19
SCHEMBL7728188 0.89 POLB (0.47) HDAC8POLBCYP1A2CYP3A4CYP2C19
SCHEMBL7727250 0.88 LTA4H (0.45) HDAC8POLBNPC1
SCHEMBL7728407 0.88 MEN1 (0.39) HDAC8POLBCYP1A2CYP3A4CYP2C19
SCHEMBL7728411 0.88 MEN1 (0.39) HDAC8POLBCYP1A2CYP3A4CYP2C19
SCHEMBL7722104 0.86 PABPC1 (0.45) HDAC8POLBCYP1A2CYP3A4CYP2C19
SCHEMBL7728829 0.84 SIRT2 (0.48) HDAC8POLB
SCHEMBL7729234 0.82 HDAC4 (0.44) HDAC8POLBCYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed